ATA45197A - Radiomarkierte somatostatin rezeptor-liganden zur diagnose und therapie - Google Patents

Radiomarkierte somatostatin rezeptor-liganden zur diagnose und therapie

Info

Publication number
ATA45197A
ATA45197A AT0045197A AT45197A ATA45197A AT A45197 A ATA45197 A AT A45197A AT 0045197 A AT0045197 A AT 0045197A AT 45197 A AT45197 A AT 45197A AT A45197 A ATA45197 A AT A45197A
Authority
AT
Austria
Prior art keywords
diagnosis
therapy
marked
radio
receptor ligands
Prior art date
Application number
AT0045197A
Other languages
English (en)
Other versions
AT405906B (de
Inventor
Peter Dr Smith-Jones
Irene Dr Virgolini
Peter Dr Angelberger
Original Assignee
Irene Dr Virgolini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Irene Dr Virgolini filed Critical Irene Dr Virgolini
Priority to AT0045197A priority Critical patent/AT405906B/de
Priority to JP53994098A priority patent/JP2001515494A/ja
Priority to AU66021/98A priority patent/AU6602198A/en
Priority to CA002284581A priority patent/CA2284581A1/en
Priority to EP98907750A priority patent/EP0975670A1/de
Priority to PCT/AT1998/000065 priority patent/WO1998041540A1/de
Publication of ATA45197A publication Critical patent/ATA45197A/de
Application granted granted Critical
Publication of AT405906B publication Critical patent/AT405906B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT0045197A 1997-03-14 1997-03-14 Radiomarkierte somatostatin rezeptor-liganden zur diagnose und therapie AT405906B (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AT0045197A AT405906B (de) 1997-03-14 1997-03-14 Radiomarkierte somatostatin rezeptor-liganden zur diagnose und therapie
JP53994098A JP2001515494A (ja) 1997-03-14 1998-03-12 診断及び治療のための放射能標識したソマトスタチン受容体リガンド
AU66021/98A AU6602198A (en) 1997-03-14 1998-03-12 Radiolabelled somatostatin receptor ligands for diagnosis and therapy
CA002284581A CA2284581A1 (en) 1997-03-14 1998-03-12 Radiolabelled somatostatin receptor ligands for diagnosis and therapy
EP98907750A EP0975670A1 (de) 1997-03-14 1998-03-12 Radiomarkierte somatostatin rezeptor-liganden zur diagnose und therapie
PCT/AT1998/000065 WO1998041540A1 (de) 1997-03-14 1998-03-12 Radiomarkierte somatostatin rezeptor-liganden zur diagnose und therapie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0045197A AT405906B (de) 1997-03-14 1997-03-14 Radiomarkierte somatostatin rezeptor-liganden zur diagnose und therapie

Publications (2)

Publication Number Publication Date
ATA45197A true ATA45197A (de) 1999-05-15
AT405906B AT405906B (de) 1999-12-27

Family

ID=3490974

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0045197A AT405906B (de) 1997-03-14 1997-03-14 Radiomarkierte somatostatin rezeptor-liganden zur diagnose und therapie

Country Status (6)

Country Link
EP (1) EP0975670A1 (de)
JP (1) JP2001515494A (de)
AT (1) AT405906B (de)
AU (1) AU6602198A (de)
CA (1) CA2284581A1 (de)
WO (1) WO1998041540A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001012234A1 (en) * 1999-08-16 2001-02-22 Uab Research Foundation Gene transfer imaging and uses thereof
US6358491B1 (en) 1999-08-27 2002-03-19 Berlex Laboratories, Inc. Somatostatin analogs
DE10002939C1 (de) * 2000-01-13 2001-09-20 Schering Ag Paramagnetische DOTA-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung für die Herstellung von pharmazeutischen Mitteln
ITMI20011708A1 (it) * 2001-08-03 2003-02-03 Bracco Imaging Spa Coniugati di peptidi, loro derivati con complessi metallici e utilizzo per i'indagine diagnostica tramite imaging per risonanza magnetica(m
US7122622B2 (en) 2002-04-16 2006-10-17 Biosynthema Inc. Peptide compounds having improved binding affinity to somatostatin receptors
EP1358890A1 (de) * 2002-05-03 2003-11-05 BioSynthema, Inc Benzothienyl-Analoge von Somatostatine, selectiv für bestimmte Somatostatinrezeptoren
CN106573077B (zh) 2014-06-30 2019-07-30 塔弗达治疗有限公司 靶向缀合物及其颗粒和制剂
JP2024521316A (ja) * 2021-06-09 2024-05-31 クリネティックス ファーマシューティカルズ，インク． 非ペプチド標的治療薬及びその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5590656A (en) * 1992-09-15 1997-01-07 The Ohio State University Research Foundation Application of peptide/cell receptor kinetics utilizing radiolabeled somatostatin congeners in the in situ, in vivo detection and differentiation of neoplastic tissue
GB9417873D0 (en) * 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs

Also Published As

Publication number Publication date
EP0975670A1 (de) 2000-02-02
JP2001515494A (ja) 2001-09-18
CA2284581A1 (en) 1998-09-24
AU6602198A (en) 1998-10-12
WO1998041540A1 (de) 1998-09-24
AT405906B (de) 1999-12-27

Similar Documents

Publication Publication Date Title
IL137919A0 (en) Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
DE19983769T1 (de) Ultraschallverfahren zur Medizinischen diagnose und System zur Elementumschaltung
DE69942614D1 (de) Vorrichtung zur diagnose und therapie von elektrophysiologischen krankheiten
EP0959908A4 (de) Neue zielgerichtete kontrastmittel für diagnostische und therapeutische verwendungen
DE69831003D1 (de) Röntgengerät für schädelaufnahmen
ATE449849T1 (de) Ob rezeptor-variante und liganden
DE69733724D1 (de) Ultraschall- Diagnose Abbildungssystem
EP1187844A4 (de) Polymorphismus der menschlichen carbamylphosphat-synthetase i und damit verbundene diagnostische und therapeutische methoden
AU137103S (en) Point of care diagnostic device
DE69535509D1 (de) Medizinische diagnostische Bilddarstellungssystem und Verfahren
NO995690D0 (no) Forbindelser for diagnose av tuberkulose og metoder for deres anvendelse
DE69835546D1 (de) Diagnostisches Mittel zur Leberfunktion
DE19781691T1 (de) Computerisiertes Optometer und medizinisches Praxismanagement-System
EP1129217A4 (de) Zusammensetzungen und verfahren zur krankheitsdiagnose und therapie
ATE337335T1 (de) Oberflächenantigene und proteine für zusammensetzungen zu diagnose und vorbeugung der lyme-kkrankheit
NO994932D0 (no) Blandinger og fremgangsmaater for behandling og diagnose av brystkreft
DE59903751D1 (de) 2',2'-difluornucleoside zur immunosuppressiven therapie und kombinationspräparate
DE69723314D1 (de) Direkte tomographische rekonstruktion
DE69821082D1 (de) Abbildungsvorrichtung und Verfahren für Computertomographie
DE69840934D1 (de) Bildgebungsvorrichtung und zahnärtzliche einheit
ATA45197A (de) Radiomarkierte somatostatin rezeptor-liganden zur diagnose und therapie
HUP0003684A3 (en) Diagnostic test for alzheimer's disease
DE69734002D1 (de) Ultraschalldiagnose gerät
DE69712982D1 (de) Mechanismus zur Prüfung und Diagnose
DE69803245D1 (de) Bilderzeugungsgerät und Bestimmung des angeschlossenen Geräts

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee